Podcasts about Florida College

It's in the News! The top diabetes stories and headlines happening now. Top stories this week include: Afrezza inhaled Insulin is Approved for Kids, CGM + Ketone Monitor gets European approval, Food Coloring & Diabetes Study, Device Recalls include Omnipod and Dexcom, Beta Bionics shares more about their patch pump, ADA conference info and more! This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcripts: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. ADA starts this week – safe travels to those of you heading to New Orleans. We'll be covering remotely so please follow on social – make sure to Like the FB page or join the group. We've got a wrap up episode planned for this podcast as well as some indepth interviews with the newsmakers from the conference. I will see some of you next week in Chicago. We have a couple of seats left for our Club 1921 dinner on June 10th in Northbrook – this is a FREE dinner for HCPs and patient leaders – all about screening for T1D. More info on the website under the events tab. Okay.. our top story this week: XX Afrezza inhaled insulin is now approved for kids and teens. The FDA okayed MannKind's afrezza for children 6 and older with type 1 and type 2 diabetes. MannKind says its proprietary Technosphere drug delivery platform enables the rapid absorption of insulin into systemic circulation. This follows FDA approval earlier this year for an update that revises recommendations for the starting mealtime dosage when patients switch from subcutaneous mealtime insulin regimens. MannKind also completed enrollment in February for a study evaluating the initiation of Afrezza therapy shortly after type 1 diabetes diagnosis in pediatric patients.   The company said it made Afrezza available for eligible patients for $35 or less per month. Desmond Schatz, professor of pediatrics at the University of Florida College of Medicine, said: "Mealtime insulin can be especially challenging for children because eating and snacking patterns, activity levels, and daily settings like school and sports often vary. With its rapid onset and dosing at the start of a meal, Afrezza may help clinicians better match insulin therapy to how children and families live day to day, while offering a needle-free mealtime option." Lots more to come on this – we're working on a bonus episode with one of the pediatric endos who worked on the clinical trials that led to this approval – hopefully have that out later this week. https://www.massdevice.com/mannkind-fda-approval-inhaled-insulin-children/ XX FDA has agreed to consider a new drug for the treatment of adults with type 1 and chronic kidney disease. Finerenone (fy-near-uh-known) is currently approved in the US for adults with CKD associated with type 2 diabetes and for adults with heart failure with left ventricular ejection fraction of 40% or greater. Chronic kidney disease (CKD) is present in over one-third of adults with diabetes, and because it's such a serious condition, interventions are needed to reduce its incidence and help people live a long and prosperous life. https://www.docwirenews.com/post/fda-grants-priority-review-to-finerenone-snda-for-type-1-diabetes-associated-ckd XX Abbot gets European approval for the world's first dual glucose‑ketone sensing technology for people with diabetes. They're calling this Libre Duo and Libre Duo 10 Day, and it's designed to continuously measure glucose and ketone levels every minute. Abbott plans to begin launching Libre Duo systems in select European countries later this year. Libre Duo delivers up to 15 days of wear and will be offered to adults ages 18 and older. Libre Duo 10 Day offers up to 10 days of wear and is intended for people ages 2 and older. Abbott is also working with leading pump companies to allow automated insulin delivery (AID) systems to connect with the sensors. https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes   XX Huge recall for Omnipod. Insulin says a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery  with specific lots of its Omnipod 5, Dash and Eros pods. Insulet said the scope of this action reaches approximately 7 million pods. This issue is separate from the March recall that affected certain Omnipod 5 lots. According to the Acton, Massachusetts-based company, some of its affected pods may have a small tear in the tubing (cannula) just above the skin. This tear lands between the pod and the point where the cannula enters the body. If this occurs, insulin may leak outside of the device instead of being fully delivered into the body as intended. This may lead to under-delivery of the therapeutic.   Individuals using an affected pod may notice wetness on the skin or pod adhesive or detect the smell of insulin. However, some cases may prove difficult to detect and go unnoticed. Of the approximately 7 million pods included in the action, approximately 60% have been consumed or are expired. The pods affected by the correction represent approximately 8.5% of the 2025 global Omnipod pod prodcution. Insulet says it has sufficient supply to replace affected pods. It expects no disruption to product availability. The company said it has notified the FDA and all other relevant regulatory authorities of its action.   The full list of affected pod lots can be found here. https://www.massdevice.com/insulet-another-omnipod-5-recall-dash-eros/ XX Dexcom is warning that certain scrapped glucose sensors have been stolen and resold. Dexcom said it has not received any reports of severe adverse events associated with the stolen product. One lot of scrapped devices carries a risk of infection for sensors that are not properly sterilized, and another lot had an elevated internal testing failure rate, meaning users would have an increased risk of having no sensor readings available. Dexcom said the affected sensors were stolen during the destruction process and then sold by third parties. The company routinely scraps sensors that do not meet its standards. The sensors are sent to a third-party vendor for destruction and recycling.   Dexcom said it traced sales of the stolen devices to Pharmsource, which is not an authorized Dexcom distributor but supplies some independent pharmacies and U.S. durable medical equipment distributors. Because of this, pharmacies that purchase products from Pharmsource should review their inventory, Dexcom said.   People with sensors from the affected lots should not use those sensors and can call customer support to request replacements. Dexcom has set up a website to help users check if their devices are affected. https://www.medtechdive.com/news/dexcom-warns-of-scrapped-glucose-sensors-being-resold/821139/ XX XX   Beta Bionics plans to debut its first insulin patch pump by the end of the second quarter of 2027, subject to Food and Drug Administration clearance. The device, called Mint, would be compatible with Beta Bionics' interoperable automated glycemic controller, a software that allows for the pump to automatically adjust insulin delivery based on readings from a glucose sensor. Beta Bionics first unveiled the prototype for Mint last year at the American Diabetes Association's Scientific Sessions. The device is expected to have a similar size and wear time, at three days, to Insulet's patch pumps on the market. It would have a 200-unit insulin reservoir.   Mint differs by containing a mix of reusable and disposable components. Beta Bionics plans to make the device exclusively available in the pharmacy channel, building on its existing agreements for its current iLet insulin pump. Beta Bionics is one of several diabetes tech companies developing patch pumps to compete with market leader Insulet. Tandem Diabetes Care and Medtronic spinoff MiniMed have also announced planned patch pumps. Tandem said it plans to file a 510(k) submission this quarter for a tubeless version of its small, durable pump, and Medtronic plans to submit its patch pump to the FDA this fall.   https://www.medtechdive.com/news/beta-bionics-to-launch-its-first-insulin-patch-pump-to-compete-with-insulet/821091/ XX CVS puts Zepbound back on it's coverage list – with it's Caremark PBM. They also added Foundayo, Lilly's obesity pill. CVS had dropped Lilly's Zepound last summer but kept competitor Wegovy. It'll be back at Caremark October first. All three of the nation's largest pharmacy ⁠benefit managers ​now cover Lilly's full obesity medicine portfolio. https://www.reuters.com/legal/litigation/cvs-brings-back-coverage-lillys-obesity-drug-zepbound-2026-05-28/   More to come, including a new benefit from metformin for women, something new from Tidepool, big news for T1D in Austalia and more.. XX A new study suggests that higher long-term exposure to food colouring additives — including both synthetic and natural colourings commonly found in processed foods and beverages — may be associated with an increased risk of developing type 2 diabetes. Researchers analyzed data from more than 108,000 adults in the French NutriNet-Santé cohort between 2009 and 2023, following participants for a median of just over eight years. During that time, 1,131 participants developed type 2 diabetes. The study found that people with the highest intake of total food colouring additives had a 38% higher risk of developing type 2 diabetes compared with non- or low-consumers.   Several specific additives were linked to increased risk, including caramel colouring additives such as total caramel (E150 family), plain caramel (E150a), sulphite ammonia caramel (E150d), and beta-carotene (E160a). Additional associations were observed for curcumin (E100), anthocyanins (E163), paprika extract (E160c), lutein (E161b), and cochineal-derived colourings (E120). "Our findings revealed positive associations between widely consumed food colouring additives and type 2 diabetes incidence," the authors wrote, adding that further research is needed to better understand the mechanisms behind the findings and whether food colouring regulations should be reevaluated. https://www.medscape.com/viewarticle/use-common-food-colours-tied-high-type-2-diabetes-risk-2026a1000hes XX Big news for Australia – their Therapeutic Goods Administration (TGA) approves Tzield. Tzield is now approved in Australia to delay the onset of stage 3 (or clinical) T1D in people aged eight years and older with stage 2 T1D – the early, pre-symptomatic stage of the condition, where changes in blood glucose levels have begun but insulin therapy is not yet required. Breakthrough T1D Australia Chief Executive Officer, Sydney Yovic, said the approval represented a transformational moment for Australians affected by T1D. https://newshub.medianet.com.au/2026/05/landmark-approval-of-tzield-in-australia-ushers-in-a-new-era-of-delay-for-type-1-diabetes/155036/ XX https://www.theatlantic.com/health/2026/05/diabetes-pregnancy/687324/ XX A common diabetes drug may hold great potential to help with aging, even if scientists aren't exactly sure why. According to a study, the drug metformin doesn't just help patients to effectively manage their type 2 diabetes. it may also give older women a better chance of living to 90. Scientists in the US and Germany used data from a long-term US study of postmenopausal women.   Records for a total of 438 people were selected – half of whom took metformin to treat diabetes, and half of whom took a different diabetes drug, sulfonylurea.   While there are some caveats and asterisks to the study, those in the metformin group were calculated to have a 30 percent lower risk of dying before the age of 90 than those in the sulfonylurea group. The study used age 90 as the marker for 'exceptional' longevity. However, scientists aren't yet sure that the drug extends lifespan, especially in humans – which is part of the reason for this study. RCTs could follow further down the line to dig deeper into these results, the researchers suggest. In the meantime, as the global population continues to skew older, studies continue to find ways to keep us healthier for longer and reduce damage to the body as we age. https://www.sciencealert.com/a-common-diabetes-drug-is-linked-with-exceptional-longevity-in-women XX The American Diabetes Association® (ADA) will host the 2026 Scientific Sessions from June 5-8 in New Orleans. The ADA's Scientific Sessions is the world's largest diabetes meeting, convening an expected audience of over 12,000 leading physicians, scientists, researchers, and healthcare professionals from around the globe. The premier diabetes meeting, which is also offered virtually, will feature the latest scientific findings in diabetes and obesity, where leading experts and peers will share findings in research for prevention, care, and cures at the Ernest N. Morial Convention Center. Key themes will include: Advancing obesity and metabolic health: Prevention, early detection, and disease modification: Improving cardiometabolic outcomes: Transforming care through innovation and access: New research will highlight how technology, artificial intelligence, and implementation strategies are reshaping diabetes care—reducing treatment burden, expanding access, and enabling more person-centered care. Advancing beta cell replacement and cure strategies: Fostering innovation: On Saturday, June 6, from 4:30-6:00 p.m., the Innovation Challenge, which debuted in 2023, invites emerging companies to pitch novel ideas to improve the lives of people living with diabetes. A panel of judges, with input from a live audience, determines which contestants will earn a private audience with potential funders. XX Tidepool, the nonprofit leader advancing innovation in diabetes technology, announced that Tidepool+ Direct Connect is now available through the Epic Showroom. Built on SMART on FHIR, Direct Connect brings interactive diabetes device data directly into Epic workflows, helping clinicians use patient data during routine care. "Tidepool has always focused on making diabetes data more accessible and actionable," said Brandon Arbiter, CEO. "We're excited to empower clinicians using Epic with insightful, intuitive patient data that fits directly into their encounter workflow so they can use it to improve care in the moment it matters."   Tidepool+ Direct Connect supports scalable deployment across Epic-enabled health systems. This architecture enables faster, more intuitive rollouts, enhancing Tidepool's existing EHR integration capabilities.   Direct Connect is part of Tidepool's ongoing work to improve how clinicians can use timely and relevant diabetes device data during patient visits to help drive better health outcomes.   The feature is now available in the Connection Hub of the Epic Showroom.   https://www.businesswire.com/news/home/20260527780274/en/Tidepool-Launches-in-Epic-Showroom-to-Bring-Diabetes-Device-Data-into-the-Point-of-Care XX

New York is waging a war against a pediatrician who dared to stand up for medical freedom, charging her with 21 felonies related to vax records of her patients. Without a trial, the state labeled Dr. Shareen Ismail a “fraud,” suspended her access, and reportedly deleted her 7-year-old son's immunization records – allegedly in an effort to portray her as an anti-vaxxer who was providing fake immunization records for her patients. Dr. Ismail and her attorney Chad Davenport join Dr. Drew to expose the state's terrifying weaponization of the justice system and the attempts to destroy her life in family courts. Dr. Tess Lawrie from the World Council for Health returns to the show to reveal explosive new findings regarding the WHO, and shares an exclusive look ahead at the massive USA Better Way Conference. Dr. Tess Lawrie is a medical doctor and research consultant based in the UK. She is CEO of Evidence-Based Medicine Consultancy (E-BMC Ltd.) and EbMC Squared, a founding member of the BiRD group, and co-founder of the World Council for Health. She served as an external consultant to the WHO from 2012 to 2021 as a Guideline Methodologist. Follow at https://x.com/lawrie_dr Dr. Shareen Ismail, MD is a specialist in pediatric emergency medicine and founder of The Alexandre Centre for Children's Health in Manlius, NY. She completed her fellowship in pediatric emergency medicine at the University of Florida College of Medicine in 2013 and has over 16 years of experience in the field. Learn more at https://instagram.com/alexandrecentreforchildren/ Chad Davenport is a New York litigator and founder of Davenport Law. Since starting his practice in 2019, he has handled 50+ civil rights cases with media coverage from CNN, Fox News, and The New York Times. He is the attorney for Dr. Shareen Ismail. Find more at https://davenport.law 「 SUPPORT OUR SPONSORS 」 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Hosted By • Dr. Drew Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/drdrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Meet Our Special Guest: Dr. PapantoniouDr. Papantoniou is a Florida native from St. Petersburg and a proud 2012 graduate of the University of Florida College of Pharmacy. Before earning his Doctor of Pharmacy degree, he spent five years working as a pharmacy technician in a high-volume retail pharmacy, gaining valuable hands-on experience in patient care and medication management.With more than 12 years of experience as a clinical compounding pharmacist, Dr. Papantoniou brings extensive knowledge and insight into men's health, wellness, stress management, preventative care, and overall health optimization.In this episode of the Fathers University Podcast, Dr. Papantoniou helps break down the biggest health challenges men face today, common health myths, warning signs fathers should never ignore, and practical ways men can take better care of themselves physically and mentally.

On this episode of Growing Kentucky's Leaders, Sheldon and Ruth Ann sit down with Patrick T. Grady, a veteran entertainer, humorist and the keynote speaker at this summer's Carol Martin Gatton Leadership Training Center. Patrick shares his journey from a Florida 4-H and FFA member to a career as a professional speaker, detailing how his roots in agricultural education shaped his life.Links:Patrick T. GradyUniversity of Florida College of Agricultural and Life SciencesCarol Martin Gatton Leadership Training Center

Hear from acclaimed author, essayist, and critic Thomas Mallon, whose novel Fellow Travelers (2007) inspired an opera and a SHOWTIME® miniseries. With exacting attention to historical detail, Mallon's novel brings to life the shameful era in the early 1950s known as the Lavender Scare, during which gay and lesbian federal employees were systematically expelled from government service. More recently, Mallon also published The Very Heart of It (2025), a collection of journal entries during his literary coming-of-age during the AIDS crisis in New York City. Reporter Katie Campbell, creator and host of the KUOW Book Club, joins Mallon for a lively discussion on these works and the lessons they hold for our own time. Thomas Mallon's eleven books of fiction include Henry and Clara, Fellow Travelers, Watergate (a Finalist for the PEN/Faulkner Award), and Up With the Sun. He has also written volumes of nonfiction about plagiarism (Stolen Words), diaries (A Book of One's Own), letters (Yours Ever,) and the Kennedy assassination (Mrs. Paine's Garage), as well as two books of essays (Rockets and Rodeos and In Fact). A collection of his personal journals, The Very Heart of It: New York Diaries, 1983-1994, was published by Knopf in June 2025. Mallon's work appears in The New Yorker, The New York Times Book Review, and other publications. He received his Ph. D. in English and American Literature from Harvard University and taught for a number of years at Vassar College. His honors include Guggenheim and Rockefeller fellowships, the National Book Critics Circle citation for reviewing, and the Harold D. Vursell Memorial Award of the American Academy of Arts and Letters, for distinguished prose style. He has been literary editor of Gentlemen's Quarterly and deputy chairman of the National Endowment for the Humanities, and in 2012, he was elected to the American Academy of Arts and Sciences. An eight-part dramatic adaptation of his novel, Fellow Travelers, is now streaming on Showtime/Paramount+, and an opera based on the novel has had over a dozen productions throughout the United States. He is Professor Emeritus of English at The George Washington University and lives in Washington, D. C. Katie Campbell is an editor and reporter for KUOW.org. She has covered a variety of local topics, including Seattle politics, elections, and the arts. She also co-hosts KUOW's weekly arts podcast, Meet Me Here, highlighting the local literary scene and visiting authors. In 2024, Katie created the KUOW Book Club, featuring stories and authors from the Pacific Northwest. Katie's picks have included classics, like Timothy Egan's The Good Rain, and recent hits, like Sonora Jha's The Laughter. Katie's interviews with the featured authors have given readers a chance to hear from some of the most talented writers in the region. All readers are invited to join the KUOW Book Club by signing up for the newsletter at kuow.org/books. Katie is a graduate of the University of Florida College of Journalism, a P-Patch gardener and an auntie. Find her on Bluesky: @katiecampbell.bsky.social

Episode 47 - Michael Tan and Dr. Jennifer Miller - Comprehensive Nutrition Management in Prader-Willi SyndromeIn this episode of Nutrition Pearls: the Podcast, co-hosts Bailey Koch and Nikki Misner speak with Michael Tan and Dr. Jennifer Miller about optimizing nutrition care in Prader-Willi syndrome from infancy to adolescence. Michael is a Registered Dietitian and Certified Diabetes Educator in the Division of Pediatric Endocrinology at the University of Florida College of Medicine. He specializes in the nutritional management of Prader-Willi Syndrome, pediatric obesity, and also works with those with type 1 and type 2 diabetes. Dr. Jennifer Miller is Professor in the Division of Pediatric Endocrinology at the University of Florida. Dr. Miller has worked with individuals with hypothalamic causes of obesity for over 20 years and has spent her career working to understand the etiology of hyperphagia and find possible treatments for individuals with Prader-Willi syndrome, hypothalamic obesity, and Schaff-Yang Syndrome. She currently follows over 600 patients with Prader-Willi syndrome from around the world. Dr. Miller's research efforts are focused on developing clinical treatment trials for individuals of all ages with hypothalamic obesity. Together they have worked with families of children with Prader-Willi Syndrome since 2018. Nutrition Pearls is supported by an educational grant from Mead Johnson Nutrition.References: Miller JL, Lynn CH, Driscoll DC, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(5):1040-1049. doi:10.1002/ajmg.a.33951Miller JL, Tan M. Dietary Management for Adolescents with Prader-Willi Syndrome. Adolesc Health Med Ther. 2020;11:113-118. Published 2020 Aug 25. doi:10.2147/AHMT.S214893Produced by: Corey IrwinNASPGHAN - Council for Pediatric Nutrition Professionalscpnp@naspghan.org

Send us Fan MailPiper hosts Plaidcast in Person in front of a live audience at Live Oak International in Ocala, Florida with Jacob Arnold, Dr. Andrew Smith and Olaf Petersen. Brought to you by Taylor, Harris Insurance Services.Host: Piper Klemm, publisher of The Plaid HorseGuest: Jacob Arnold is one of the United States' top combined driving athletes. Originally from Snow Camp, NC, he began driving at age 8 with the family pony and went on to earn the title of USEF Junior Equestrian of the Year in 2011. He has represented the U.S. at five FEI World Championships and won the Single Horse Marathon at the 2014 World Championships. He is also a multiple-time USEF National Champion in both pair horses and pair ponies. Today, Jacob runs JA Combined Driving, where he continues competing at the highest levels of the sport while helping grow combined driving in the US.Guest: Dr. Andrew Smith is an equine surgeon at Peterson Smith Equine Hospital + Complete Care in Florida. A lifelong horseman who started out riding cutting horses as a teenager, he obtained his Doctor of Veterinary Medicine degree from the North Carolina State University College of Veterinary Medicine before completing a surgical residency and Ph.D at the University of Florida College of Veterinary Medicine. His research has focused on advanced imaging and new treatments for osteoarthritis in horses. Dr. Smith became board-certified by the American College of Veterinary Surgeons in 2017 and previously practiced at Woodside Equine Clinic in Virginia before returning to Florida. Guest: Olaf Petersen is an FEI Level 4 Course Designer, and has designed tracks for Longines FEI World Cup Qualifiers at over 13 locations in 10 different countries. His course designing career began in 1990, and he earned his International Course Designer status from the FEI in 2002. He served as Co-Course Designer at the Olympic Games in Athens in 2004. He then designed the Southeast Asian Games in Manila in 2005 and the Asian Games in Doha in 2006. Olaf returns to Live Oak International for the fifth time.Subscribe To: The Plaid Horse MagazineTitle Sponsor: Taylor, Harris Insurance ServicesSponsor: TerraNova Equestrian Center, Equine Affaire, Sentinel and World Equestrian Center Join us at an upcoming Plaidcast in Person event!

What if erectile dysfunction could be treated without surgery or lifelong medication?In this episode, I'm joined by Dr. Kendrick Heywood to discuss the future of regenerative treatments for erectile dysfunction and sexual wellness. We break down how therapies like acoustic shockwave therapy, the P-Shot (PRP), exosomes, and hormone optimization help restore blood flow, repair tissue, and improve sexual performance. Today, we also explore emerging innovations like focused shockwave therapy, RF treatments, and hyperbaric oxygen therapy, and how regenerative medicine is bridging the gap between ED medications and surgical implants.Dr. Heywood specializes in functional medicine, regenerative therapies, and age management. A University of Florida College of Medicine graduate, he completed his residency at Jackson Memorial Hospital and now focuses on optimizing longevity, performance, and sexual health through advanced regenerative therapies. He is also a member of the American Academy of Anti-Aging Medicine (A4M).

Send a textWhat if erectile dysfunction could be treated without surgery or lifelong medication?In this episode, I'm joined by Dr. Kendrick Heywood to discuss the future of regenerative treatments for erectile dysfunction and sexual wellness. We break down how therapies like acoustic shockwave therapy, the P-Shot (PRP), exosomes, and hormone optimization help restore blood flow, repair tissue, and improve sexual performance. Today, we also explore emerging innovations like focused shockwave therapy, RF treatments, and hyperbaric oxygen therapy, and how regenerative medicine is bridging the gap between ED medications and surgical implants.Dr. Heywood specializes in functional medicine, regenerative therapies, and age management. A University of Florida College of Medicine graduate, he completed his residency at Jackson Memorial Hospital and now focuses on optimizing longevity, performance, and sexual health through advanced regenerative therapies. He is also a member of the American Academy of Anti-Aging Medicine (A4M).

Dr. Gary Richter was born in New York City and was raised in Miami, Florida. From a young age he had an interest in veterinary medicine, especially wildlife medicine. He volunteered at the Miami Zoo, worked in small animal practice as an assistant, and worked for the University of Florida College of Veterinary Medicine as an undergraduate. He earned his Bachelor's, Master's, and DVM from the University of Florida, graduating with a DVM in 1998 with honors.After graduation, he moved to California to work in emergency and general practice before purchasing a small animal practice, which he owned for sixteen years. During that time, he started his holistic education and started a second practice, Holistic Veterinary Care, which he works in to this day.In addition to his clinical work, Dr. Richter co-founded the Veterinary Cannabis Society, has consulted in the formulation of pet cannabis products and natural supplements for pets, is the founder of a startup developing a wearable biometric device for pets, is a consultant for Hemopet Labs, and has written and lectured extensively on allopathic and holistic veterinary topics.Please enjoy this conversation with Dr. Gary Richter as we discuss his education, clinical practice, industry work, and his involvement with the American Holistic Veterinary Medical Foundation.

My guest today on the Online for Authors podcast is Steven Scott Eichenblatt, author of the book Pretend They are Dead. Steven is a graduate of Florida State University and the University of Florida College of Law. A practicing attorney and father of five, he has spent over thirty years advocating for children as a pro bono guardian ad litem and representing families of first responders killed on 9/11. As a founding partner of Page & Eichenblatt, he has received multiple awards for legal excellence and community work supporting children. He lives with his wife in Orlando, Florida.   In my book review, I stated Pretend They Are Dead is heartbreaking memoir. Steven's father had issues - enough that his parents divorced. She remarried a man who was verbally and physically abusive. Although, technically, Steven had two fathers, he felt abandoned by both. By the time he graduated high school, he called no one dad.   The trauma from his youth made it impossible to have lasting relationships, though he tried, failing at two marriages. But something he didn't want to fail at was being a father. So, he loved his children with everything he had and worked hard to figure out the truth of his past.   I like Steven's style of writing. I felt like I was in his head - which spins from one topic to the next. I could see why he exasperated his parents at a young age! He is also honest - about his own actions as well as the actions of others. Despite the circumstances, in the end, he doesn't really cast blame. Instead, he figures out how to forgive, let the past go, and find joy in today.   If you like a good memoir, you'll like this book!   Subscribe to Online for Authors to learn about more great books! https://www.youtube.com/@onlineforauthors?sub_confirmation=1   Join the Novels N Latte Book Club community to discuss this and other books with like-minded readers: https://www.facebook.com/groups/3576519880426290   You can follow Author Steven Scott Eichenblatt Website: https://www.stevenscotteichenblatt.com/ FB: @seichenblatt IG: @seichenblatt X: @SSEichenblatt LinkedIn: @Steven Eichenblatt   Purchase Pretend They are Dead on Amazon: Paperback: https://amzn.to/3NGK72R Ebook: https://amzn.to/4qQtzE4   Teri M Brown, Author and Podcast Host: https://www.terimbrown.com FB: @TeriMBrownAuthor IG: @terimbrown_author X: @terimbrown1   Want to be a guest on Online for Authors? Send Teri M Brown a message on PodMatch, here: https://www.podmatch.com/member/onlineforauthors   #stevenscotteichenblatt #pretendtheyaredead #memoir #terimbrownauthor #authorpodcast #onlineforauthors #characterdriven #researchjunkie #awardwinningauthor #podcasthost #podcast #readerpodcast #bookpodcast #writerpodcast #author #books #goodreads #bookclub #fiction #writer #bookreview *As an Amazon Associate I earn from qualifying purchases.

Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by integrated vascular surgery resident Falen Demsas, JVS editor Dr. Duncan (@ADuncanVasc), JVS-VI editor-in-chief Dr. Dua (@AnahitaDua) to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Huber, Dr. Fassler, Nishanth Konduru (@n_konduru), and Dr. Rao.   Articles:   Outcomes of open bypass and superior mesenteric artery endarterectomy for patients with chronic mesenteric ischemia resulting from long-segment superior mesenteric artery occlusive disease Retrograde tibiopedal access as an alternative procedural technique for genicular artery embolization    Show Guests  Dr. Huber Former Division Chief (served as Chief for 13 years) of Vascular Surgery at the University of Florida and the Edward R. Woodward Professor of Surgery at the University of Florida College of Medicine. He was also the chair of the writing committee for the SVS Guidelines on Chronic Mesenteric Ischemia. Dr. Fassler PGY-4 General Surgery resident at the University of Florida.  Nishanth Konduru Fourth year undergraduate at the University of North Carolina Chapel Hill Dr. Rao Interventional cardiologist with Vascular Solutions of North Carolina.   Founder of Rao Clinic https://www.raoclinic.org/ Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.   *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.  

Steve Eichenblatt joins Let's Talk Memoir for a conversation about losing a father through abandonment, the abuse he endured from his adoptive father, living in a household of trauma, feeling emotionally disconnected, verbal abuse and the wounds that don't go away, embracing vulnerability and learning how to connect, writing and processing old, longstanding anger, sharing manuscripts with family before publication, the response to our narratives from siblings and parents, fighting for our voice and agency, learning to help ourselves, being accountable, and the 10-year process of writing his new memoir Pretend They Are Dead. Also in this episode: -not giving up -finding your writing space and time -writing without boundaries    Books mentioned in this episode: -Angela's Ashes by Frank McCourt -Catcher in the Rye by J.D. Salinger -The Great Santini by Pat Conroy -Stay True by Hua Hsa   Steven Scott Eichenblatt is a graduate of Florida State University and the University of Florida College of Law. A practicing attorney with Page and Eichenblatt, and father of five, he has spent over thirty years advocating for children as a pro bono guardian ad litem and representing families of first responders killed on 9/11. He lives with his wife, Melissa Ross, in Orlando, Florida.   Connect with Steve: Website: www.stevenscotteichenblatt.com   Ronit's upcoming 10-week online memoir course: https://www.pce.uw.edu/courses/memoir-writing-finding-your-story   – Ronit's writing has appeared in The Atlantic, The Rumpus, The New York Times, Poets & Writers, The Iowa Review, Hippocampus, The Washington Post, Writer's Digest, American Literary Review, and elsewhere. Her memoir WHEN SHE COMES BACK about the loss of her mother to the guru Bhagwan Shree Rajneesh and their eventual reconciliation was named Finalist in the 2021 Housatonic Awards Awards, the 2021 Indie Excellence Awards, and was a 2021 Book Riot Best True Crime Book. Her short story collection HOME IS A MADE-UP PLACE won Hidden River Arts' 2020 Eludia Award and the 2023 Page Turner Awards for Short Stories.  She earned an MFA in Nonfiction Writing at Pacific University, is Creative Nonfiction Editor at The Citron Review, and teaches memoir through the University of Washington's Online Continuum Program and also independently. She launched Let's Talk Memoir in 2022, lives in Seattle with her family of people and dogs, and is at work on her next book. More about Ronit: https://ronitplank.com Subscribe to Ronit's Substack: https://substack.com/@ronitplank Follow Ronit: https://www.instagram.com/ronitplank/ https://www.facebook.com/RonitPlank https://bsky.app/profile/ronitplank.bsky.social

We're thrilled to welcome back one of our favorite guests, board-certified veterinary dentist Dr. Sharon Hoffman, for a deep dive into a topic pet owners frequently ask about: anesthesia safety during pet dental procedures.For this special "Take Two" episode, Dr. Hoffman is joined by veterinary anesthesiologist Dr. Carolyn McKune, founder of Mythos Vet LLC. This dynamic duo brings their combined expertise to demystify the critical role of anesthesia in veterinary procedures, ensuring your pet receives the safest, most effective dental care possible.In this enlightening conversation, they cover:The essential need for anesthesia in comprehensive pet dental care and the risks of skipping it.The importance of a thorough pre-operative evaluation and how pet anxiety can be managed.Understanding the complete anesthesia period, from pre-op to post-op recovery.Answers to pet owner FAQs, including the significance of IV catheters and how to best prepare your pet for surgery.Debunking common myths, such as the idea that small pets are at higher risk.The crucial role of pain management and customizing care for pets with pre-existing conditions.Tune in to gain peace of mind and the knowledge you need to confidently manage your pet's oral health journey.Dr. Hoffman is not only a board-certified veterinary dentist but also a diplomat of the American Veterinary Dental College. She earned her DVM from Louisiana State University and now runs her own veterinary dental consulting practice in Florida, while also teaching at the University of Florida College of Veterinary Medicine.Dr. Carolyn McKune, a Michigan native and proud Spartan. Carolyn earned her veterinary degree from Michigan State University, completed an internship at Washington State University, and then did a residency in anesthesia and critical care at UC Davis. She became board-certified in 2009 and, after a stint on the faculty at the University of Florida, launched her own independent anesthesia consulting service, Mythos Vet LLC.--What started during the COVID-19 lockdown with one baby gorilla at the Cleveland Zoo has grown into a channel loved by animal fans around the world. I'm a one-person operation—filming, editing, narrating, and sharing the most heartfelt moments of baby gorillas, orangutans, elephants, and other zoo animals. Whether it's Jameela's emotional journey or Clementine's first steps, each video brings you closer to the animals and their stories. If you love watching real animal behavior, learning fun facts, and supporting conservation through storytelling—this is your place! Subscribe to Larry's Animal Safari on YouTube @larrysanimalsafari ---Support our sponsor for this episode Blue Buffalo by visiting bluebuffalo.com. BLUE Natural Veterinary Diet formulas offer the natural alternative in nutritional therapy. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents.---All footage is owned by SLA Video Productions.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BWD865. CME/MOC/NCPD/CPE/AAPA credit will be available until November 30, 2026.RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast CancerThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BWD865. CME/MOC/NCPD/CPE/AAPA credit will be available until November 30, 2026.RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast CancerThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Florida St vs. Florida College Football Pick Prediction 11/29/2025 by Tony T. Recent Box Score Key Stats Florida St at Florida 4:30 PM ET—Florida St is 5-6 following their 21-11 home defeat to NC State. The Seminoles had movement in their passing game and rushed for 180 yards for 5.3 yards per carry. On defense they allowed 3.2 yards per run with 152 yards passing for 5.8 yards per pass attempt.

In this compelling episode of the Crackin' Backs Podcast, we sit down with Dr. Andria Klioze—physician, disease-reversal pioneer, and founder of the wellness platform Shield of Life. After years inside the rule-bound system of the Veterans Affairs (VA) caring for patients with advanced illnesses, Dr. Klioze made a bold decision: to leave the traditional structure and build a new model of care focused on gut health, soil microbiome, energy medicine, and true resilience.In this episode you'll learn:What it costs a doctor to trade “prescriptions for possibility,” and how hope, truth, love and faith can meet evidence-based medicine.The hardest lessons she had to unlearn after stepping away from the VA, and what healing really looks like when you remove bureaucracy.Why she calls her garden philosophy – and how the soil beneath your feet may reflect the health within your body.Her breakthrough integration of the human gut microbiome, soil biology and pulsed electromagnetic activation (PEMA), uniting energy medicine and biology.A life-changing patient story that redefines “reversal,” and the tools she uses when everyday life feels numb or cynical to keep belief alive.Whether you're looking for ways to reverse disease, reboot your health, or question the limits of modern medicine, this discussion cuts deep. It's for the seekers, the skeptics, and anyone ready to step into possibility.About Dr. Andria Klioze:Dr. Klioze graduated from the Eastern Virginia Medical School in 1995, completed her residency in internal medicine at the University of Florida College of Medicine in 1999 and a fellowship in faculty development in 2002. She is board-certified in Internal Medicine and Obesity Medicine. In 2002 she left her role as Director of Faculty Development at UF and as a hospitalist for the VA in Gainesville, to work in the VA's new metabolic clinic in Daytona Beach. Today she leads Shield of Life, a physician-led program that focuses on disease-mitigation, remission and reversal through holistic, science-driven protocols.Learn more & connect with Dr. Klioze: Website: Shield for Life Instagram: @drandriaklioze Facebook: Shield of Life Facebook Page(Check for her podcast, webinars and educational series at her site.)Don't miss this—tap in now and discover what modern medicine misses, what your body knows, and how one physician is rewriting the rules of healing.We are two sports chiropractors, seeking knowledge from some of the best resources in the world of health. From our perspective, health is more than just “Crackin Backs” but a deep dive into physical, mental, and nutritional well-being philosophies. Join us as we talk to some of the greatest minds and discover some of the most incredible gems you can use to maintain a higher level of health. Crackin Backs Podcast

What is Targeted Reproductive Management (TRM)? And why should producers care about this new approach to dairy reproduction? Listen in to this Progressive Dairy sponsorcast as a team of reproductive health experts and enthusiasts evaluate new TRM best practices, how dairies can find better repro rates and more. Episode Highlights The latest reproductive research findingsProstaglandin product comparisonsTRM cost-benefit analysis Episode Guests Dr. Bilby, Merck Animal Health Director of Dairy Technical ServicesAustin Snook, Merck Animal Health U.S. Dairy Marketing ManagerDr. Ricardo Chebel, University of Florida College of Veterinary Medicine Professor This episode is sponsored by Merck Animal Health. With identification, monitoring and biopharma products fully integrated in one portfolio, Merck Animal Health offers the only true full-solution approach in the dairy industry. Which means you get the tools you need to eliminate guesswork, solve specific problems, let cows be cows and put more milk in the tank. It's the way you want to work, working better than ever before. Learn more about this unique approach to dairy at M-Power-Dairy.com.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose.  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Think healing from childhood trauma is impossible? Betsy Wurzel and Steven Eichenblatt prove it's not—through truth, courage, and forgiveness.In this heartfelt interview, Betsy Wurzel speaks with Steven Eichenblatt, author of Pretend They Are Dead: A Father's Search for the Truth, about transforming trauma into triumph through courage, forgiveness, and self-awareness. Steven's memoir became a #1 Amazon bestseller in both New Releases: Dysfunctional Families and Lawyer & Judge Biographies, sharing a raw look into emotional pain and resilience.Steven revealed the title's chilling origin—advice once given to his biological father, Allen Nestlé, by a psychiatrist. He recounted abandonment, emotional hardship, and years of silence that shaped his understanding of survival. Together, Betsy and Steven explored how unresolved childhood wounds can shadow adulthood and limit our ability to connect. They discussed how the 1960s and 1970s often silenced abuse survivors, especially women who felt pressured to endure harmful behavior. Steven emphasized choosing not to remain a victim but to reclaim one's story and live victoriously. One haunting revelation came when Steven described witnessing a fatal crash at sixteen—only to learn decades later that the victim was his father. Writing Pretend They Are Dead forced him to confront buried memories yet ultimately freed him to move forward with compassion and strength. Betsy praised the memoir as raw, emotional, and deeply inspiring. “This was a page-turner,” she shared. “I laughed, I cried, and I wanted to hug young Steven.” 

In this episode, Drs. Rob Assibey and Cynthia Chen-Joea meet live at Family Medicine POP in San Diego with Dr. Mikah Owen, Senior Director of Clinical and Academic Programs and Health Equity at UCAAN to talk about Adverse Childhood Experiences (ACEs) & Trauma Informed Resilience Oriented Healthcare (TIROH). GUESTS Mikah Owen, MD, MPH, MBA - Senior Director of Clinical and Academic Programs and Health Equity, UCAAN Based in the Sacramento area, Dr. Owen is a social pediatrician who has dedicated his career to improving the health and well-being of children and adolescents from marginalized and vulnerable backgrounds, especially those with involvement in the child welfare and juvenile justice systems. Dr. Owen has been a long-time adviser to the ACEs Aware initiative and has joined the UCLA-UCSF ACEs Aware Family Resilience Network (UCAAN) as Co-Principal Investigator. Prior to joining UCAAN, Dr. Owen was an Assistant Clinical Professor in the Department of Pediatrics at UC Davis Health. Dr. Owen earned an MD at UCSF, completed his Pediatric Residency at UC Davis, and completed his fellowship in Community and Societal Pediatrics at the University of Florida College of Medicine – Jacksonville. He recently completed the Pozen-Commonwealth Fund Fellowship in Health Equity Leadership at Yale University. The Family Docs Podcast is hosted by Rob Assibey, MD, FAAFP & Cynthia Chen-Joea, DO, FAAFP. RESOURCES CAFP ACEs & TIROH site - https://www.familydocs.org/aces Live Beyond Campaign materials - https://livebeyondca.org  Becoming ACEs Aware in California training - https://training.acesaware.org/aa  Family Medicine POP: Prism of Practice conference, August 21-23, 2026 (San Diego) - www.familydocs.org/pop  CAFP's All Member Advocacy Meeting (AMAM), March 14-16, 2026 (Sacramento) - www.familydocs.org/amam   Information: The Family Docs Podcast is hosted by Rob Assibey, MD, FAAFP and Cynthia Chen-Joea, DO, FAAFP.  The Family Docs podcast is developed, produced, and recorded by the California Academy of Family Physicians. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent or the California Academy of Family Physicians. More information at www.familydocs.org/podcast. Visit the California Academy of Family Physicians online at www.familydocs.org. Follow us on social media: Twitter - https://twitter.com/cafp_familydocs  Instagram - https://www.instagram.com/cafp_familydocs  Facebook - https://www.facebook.com/familydocs  LinkedIn - https://www.linkedin.com/company/california-academy-of-family-physicians   

Texas vs. Florida College Football Week 6 Betting Odds & Picks, 10/4/25 | Night Moves Show byRamon Scott

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical CenterThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical CenterThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical CenterThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical CenterThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical CenterThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical CenterThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Dr. Anthea Mazzawi joins host Dr. Joel Berg to share her story as a dual pediatric dentist and orthodontist, a practice-owner and a mother. She delves into how the multifaceted roles have shaped her as a professional and leader, especially the opportunities to foster a network of peer experts. Dr. Mazzawi emphasizes the importance of a willingness to learn and Guest Bio: Dr. Anthea Mazzawi is a board-certified pediatric dentist who has practiced dentistry for almost 20 years. Raised along the gulf coast of Florida, she earned a B.S. degree in Developmental Biology from Florida State University and a D.M.D. degree from the University of Florida College of Dentistry. She then completed a residency in pediatric dentistry at the Medical University of South Carolina. She is currently in private practice with her husband, Dr. Miles Mazzawi, who is also a pediatric dentist. Their practice, Cherokee Children's Dentistry, has been serving the needs of children in the greater Atlanta area since 2007. Mazzawi is passionate about working with children and serving as an advocate for all child related issues. Mazzawi has been heavily involved with the American Academy of Pediatric Dentistry and organized dentistry throughout her career. She served as the president of The College of Diplomates of the American Board of Pediatric Dentistry in 2018 and has also been a part of several committees and councils for the American Academy of Pediatric Dentistry. Currently, she is the chairman of the Scientific Program Committee for the Annual Session. She also serves chairman of the Greater Atlanta Dental Foundation Gala Committee (an event that raises funds to meet the needs of several free/reduced fee clinics in Atlanta), and the secretary for the GA Academy of Pediatric Dentistry. Mazzawi is excited to serve as a trustee on the board of trustees for the AAPD. She looks forward to working with her colleagues, specifically the federal service membership, to promote for our profession and advance optimal oral health for all children. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

When the rule of law comes under attack, who speaks up? In Georgia, more than 400 lawyers have come together to form Georgia Lawyers for the Rule of Law — the only statewide group dedicated to defending judges, lawyers, and the integrity of our justice system. In this powerful episode of See You In Court, hosts Robin Frazer Clark and Lester Tate welcome Seth Kirschenbaum and Lynne Borsuk to share: Why they launched this nonpartisan effort How threats against judges and law firms erode confidence in justice What ordinary citizens and lawyers alike can do to protect due process Their message is clear: justice is not partisan — it's the foundation of our democracy.

How Are You Wired? Is a leadership podcast developed by local  basketball coaches, Joe Willis (Plant High School) and Billy Teeden (Florida College). In this episode, Coach Teeden and Coach Willis speak with Brian Blackburn, head basketball coach at Florida College, about how he is wired and how his core values has allowed him to build successful programs. 

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Michael Radcliffe to the podcast! Michael Radcliffe, DPM is a fellowship-trained podiatric surgeon at the Foot & Ankle Centers of North Houston, serving the community where he was raised in Kingwood, Texas. He earned his undergraduate degree from the University of Texas at Austin, volunteered as an EMT, then completed his Doctorate of Podiatric Medicine at Des Moines University. Dr. Radcliffe's surgical residency took place at the University of Florida College of Medicine in Jacksonville, where he served as Chief Resident and was honored as the Most Outstanding Resident and for Excellence in Teaching. To further refine his surgical expertise, he completed a prestigious fellowship at the Phoenix Foot and Ankle Institute, specializing in total ankle replacement, complex reconstruction, sports medicine, arthroscopy, minimally invasive surgery, trauma, and diabetic limb salvage  . Dr. Radcliffe has also contributed to the field through peer-reviewed publications, academic presentations, and by mentoring upcoming podiatric surgeons. Enjoy this discussion with an energetic young leader in our profession!

Progressive supranuclear palsy and corticobasal syndrome are closely related neurodegenerative disorders that present with progressive parkinsonism and multiple other features that overlap clinically and neuropathologically. Early recognition is critical to provide appropriate treatment and supportive care. In this episode, Teshamae Monteith, MD, FAAN speaks with Nikolaus R. McFarland, MD, PhD, FAAN, author of the article “Progressive Supranuclear Palsy and Corticobasal Syndrome” in the Continuum® August 2025 Movement Disorders issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. McFarland is an associate professor of neurology at the University of Florida College of Medicine at the Norman Fixel Institute for Neurological Diseases in Gainesville, Florida. Additional Resources  Read the article: Progressive Supranuclear Palsy and Corticobasal Syndrome Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: Hi, this is Dr Teshamae Monteith. Today I'm interviewing Dr Nikolaus McFarland about his article on progressive supranuclear palsy and cortical basilar syndrome, which appears in the August 2025 Continuum issue on movement disorders. Welcome, how are you? Dr Farland: I'm great. Thank you for inviting me to do this. This is a great opportunity. I had fun putting this article together, and it's part of my passion. Dr Monteith: Yes, I know that. You sit on the board with me in the Florida Society of Neurology and I've seen your lectures. You're very passionate about this. And so why don't you first start off with introducing yourself, and then tell us just a little bit about what got you interested in this field. Dr Farland: I'm Dr Nicholas McFarlane. I'm an associate professor at the University of Florida, and I work at the Norman Fixel Institute for Neurological Diseases. I am a director of a number of different centers. So, I actually direct the cure PSP Center of Care and the MSA Center of Excellence at the University of Florida; I also direct the Huntington's clinic there as well. But for many years my focus has been on atypical parkinsonisms. And, you know, I've treated these patients for years, and one of my focuses is actually these patients who suffer from progressive supranuclear palsy and corticobasal syndrome. So that's kind of what this review is all about. Dr Monteith: You probably were born excited, but I want to know what got you interested in this in particular? Dr Farland: So, what got me interested in this in particular was really the disease and the challenges that's involved in it. So, Parkinson's disease is pretty common, and we see a lot of that in our clinic. Yet many times, roughly about 10 to 15% of my patients present with these atypical disorders. And they're quite fascinating. They present in different ways. They're fairly uncommon. They're complex disorders that progress fairly rapidly, and they have multiple different features. They're sort of exciting to see clinically as a neurologist. I think they're really interesting from an academic standpoint, but also in the standpoint of really trying to bring together sort of a team. We have built a multidisciplinary team here at the University of Florida to take care of these patients. They require a number of folks on that team to take care of them. And so, what's exciting, really, is the challenge of treating these patients. There are very limited numbers of therapies that are available, and the current therapies that we have often really aren't great and over time they fail. And so, part of the challenge is actually doing research. And so, there's actually a lot of new research that's been going on in this field. Recently, there's been some revisions to the clinical criteria to help diagnose these disorders. So, that's really what's exciting. The field is really moving forward fairly rapidly with a number of new diagnostics, therapeutics coming out. And hopefully we can make a real difference for these patients. And so that's what really got me into this field, the challenge of trying to treat these patients, help them, advocate for them and make them better. Dr Monteith: And so, tell me what the essential points of this article. Dr Farland: So, the essential points, really, of this article is: number one, you know, just to recognize the new clinical criteria for both PSP and corticobasal syndrome, the diagnosis for these disorders or the phenotypic spectrum has really expanded over the years. So, we now recognize many different phenotypes of these disorders, and the diagnosis has gotten fairly complicated. And so, one of the goals of this article was to review those new diagnostic criteria and the different phenotypic ways these diseases present. I wanted to discuss, also, some of the neuropathology and clinicopathological overlap that's occurred in these diseases as well as some of the new diagnostic tests that are available. That's definitely growing. Some of the new studies that are out, in terms of research and clinical trials. And then wanted to review some of the approaches for treatment for neurologists. Particularly, we're hoping that, you know, this article educates folks. If you're a general neurologist, we're hoping that recognizing these diseases early on will prompt you to refer these patients to specialty clinics or movement disorder specialists early on so they can get appropriate care, confirm your diagnosis, as well as get them involved in trials if they are available. Dr Monteith: And how has the clinical criteria for PSP and cortical basilar syndrome changed? Dr Farland: I think I already mentioned there's been an evolution of the clinical criteria for PSP. There's new diagnostic criteria that were recently published, and it recognizes the multiple clinical phenotypes and the spectrum of the disease that's out there, which is much broader than we thought about. Corticobasal clinical criteria are the Dr Armstrong criteria from 2013. They have not been updated, but they are in the works of being updated. But it does recognize the classic presentation of corticobasal syndrome, plus a frontal executive predominant and then a variant that actually overlaps with PSP. So, there's a lot more overlap in these two diseases than we originally recognized. Dr Monteith: And so, you spoke a bit about FTD spectrum. So why don't you tell us a little bit about what that is? I know you mentioned multiple phenotypes. Dr Farland: What I really want to say is that both PSP and corticobasal syndrome, they're relatively rare, and what- sort of as to common features, they both are progressive Parkinson disorders, but they have variable features. While they're commonly associated with Parkinson's, they also fit within this frontotemporal lobar spectrum, having features that overlap both clinically and neuropathologically. I just want folks to understand that overlap. One of this pathological overlap here is the predominant Tau pathology in the brain, an increasing recognology- recognition of sort of the pathological heterogeneity within these disorders. So, there's an initial description, a classic of PSP, as Richardson syndrome. But now we recognize there are lots of different features to it and there are different ways it presents, and there's definitely a lot of clinical pathological overlap. Dr Monteith: Why don't we just talk about some red flags for PSP? Dr Farland: Yeah, sure. So, some of the red flags for PSP and even corticobasal syndrome are: number one is rapid progression with early onset of falls, gait difficulty, falling typically backwards, early speech and swallow problems that are more prominent than you see in Parkinson's disease, as well as eye gaze issues. So, ocular motor features, particularly vertical gaze palsy. In particular what we talk about is the supranuclear gaze palsy, and one of the most sensitive features that we've seen with these is downgaze limitation or slowed downgaze, and eventually a full vertical gaze palsy and followed supranuclear gaze palsy. So, there's some of the red flags that we see. So, while we think about the lack of response to levodopa frequently as something that's a red flag for Parkinson's, there are many times that we see Parkinson's patients, and about a quarter of them don't really respond. There's some features that don't respond to levodopa that may not be so specific, but also can be helpful in this disease. Dr Monteith: And what about the red flags for cortical basilar syndrome? Dr Farland: So, for cortical basilar syndrome, some of the red flags again are this rapidly depressive syndrome tends to be, at least in its classical present presentation, more asymmetric in its presentation of parkinsonism, with features including things like dystonic features, okay? For limb dystonia and apraxias---so, inability to do a learned behavior. One of those red flags is a patient who comes in and says, my hand doesn't work anymore, which is something extremely uncommon that you hear in Parkinson's disease. Most of those patients will present, say, I might have a tremor, but they very rarely will tell you that I can't use my hand. So look out for that sign. Dr Monteith: And let's talk a little bit about some of the advances in the fields you mentioned, evolving biomarker and imaging capacities. So, how are these advances useful in helping us understand these conditions, especially when there's so much heterogeneity? Dr Farland: I might start by talking a little bit about some of the clinical criteria that have advanced. Why don't we start there and just discuss some of the advances? I think in PSP, I think, originally we had both probable and possible diagnoses of PSP, and the diagnostic criteria were basically focused on what was what's called “classical PSP” or “Richardson syndrome”. But now we recognize that there are multiple phenotypes. There's an overlap with Parkinsonism that's slower in progression and morphs into PSP, the classical form. There's a frontal behavioral variant where patients present with that frontal behavioral kind of thing. There's a speech-language variant that can overlap with PSP. So they have prominent speech language, potentially even apraxia speech. So, recognition of these different phenotypes is sort of a new thing in this field. There's even overlap with cortical basal syndrome and PSP, and we note that the pathology can overlap as well. So, I think that's one of the things that have changed over time. And these were- recently came out in 2017 in a new publication in the Movement Disorders Society. So, in terms of diagnostic tests as well---and there's been quite a bit of evolution---really still to date, our best diagnostic test is imaging. MRI is really one of our best tests currently. Currently blood tests, spinal fluid, there's new biomarkers in terms of skin… they're still in the research phase and not necessarily very specific yet. So, we rely heavily on imaging still; and for PSP, what we're looking for largely are changes in the brain stem, and particularly focused on the midbrain. So disproportionate midbrain atrophy compared to the pons and the rest of the midbrain is a fairly specific intensive sign for PSP. Whereas in MSA we see more of a pontine atrophy compared to the midbrain. So that can be really helpful, and there are lots of different new measurements that can be done. PET scans are also being used as well. And there are new PET markers, but they still remain kind of research-based, but are becoming more and more prevalent and may be available soon for potential use. Although there's some overlap with PET tracers with Alzheimer's disease and different Tau isoforms. So, something to be wary about, but we will be seeing some of these soon coming out as well. More kind of up-to-date things include things like the spinal fluid as well as even some of the skin biopsies. And I think we've heard some word of recent studies that have come out that potentially in the very near future we might actually have some Tau protein tests that we can look at Tau either in spinal fluid or even in a skin biopsy. But again, still remains research-based and, we still need more information as to whether these tests can be reproducible and how sensitive or specific they are. Dr Monteith: It sounds like, when really approaching these patients, still, it's a lot of back to the history, back to the clinical and some basic imaging that we should be able to identify to distinguish these types of patients, and we're not quite where we need to be yet for biomarker. Dr Farland: I totally agree with you. I think it starts, really, with the clinical exam and that's our main focus here; and understanding some of the new clinical criteria which are more sensitive, but also specific, too. And they're really useful to look at. So, I think reviewing those; patients do progress, following them over time can be really useful. And then for diagnosis, getting imaging if you suspect a patient has an atypical presentation of parkinsonism, to look for signs or features that might be specific for these different disorders. Dr Monteith: Why don't we take a typical case, a typical patient that you would see in clinic, and walk us through the thought process---especially, maybe they presented somewhat early---and the different treatment approaches to helping the patient, and of course their family. Dr Farland: Yeah, sure. So, a typical patient might be someone who comes in with, like, a three year history of progressive gait problems and falling. And let's say the patient says, I'm falling backwards frequently. They may have had, like, a rib fracture, or they hit their head once, and they're describing some speech issues as well. Now they're relying on a walker and family members saying they rarely let them be by themselves. And there may be some slowing of their cognitive function and maybe a bit of withdrawal. So that's a typical patient. So, the approach here is really, what are some of the red flags? I think already you hear a red flag of a rapidly progressive disease. So, Parkinson's disease patients rarely have frequent falls within the first five years. So, this is within three years or less. You're already hearing early onset of gait problems and falling, and particularly falling backwards rather than forwards as often Parkinson's disease patients do. You're hearing early speech problems and maybe a subtle hint of cognitive slowing and some withdrawal. So, a lot of things that sort of are red flags. So, our approach really would be examining this patient really closely. Okay? We'd be listening to the history, looking at the patient. One thing is that some of these patients come in, they may be in a wheelchair already. That's a red flag for us. If they're wearing sunglasses---sometimes we see that patients, they have photosensitivity and they're in a chair and they're wearing sunglasses---you take the glasses off and you look at their face and they have that sort of a facial stare to them---not just the masked face, but the stare---and their eyes really aren't moving. So, another kind of clue, maybe this is probably something atypical, particularly PSP is what I'm thinking about. So, the approach is really, do a thorough exam. I always recommend looking at eye movements and starting with volitional saccades, not giving them a target necessarily, but asking them to look up and then look down. And then particularly look at the speed of downgaze and whether they actually have full versions down, are able to do that. That's probably your most sensitive test for a patient who has PSP. Not the upgaze, which can be- upgaze impairment in older patients can be nonspecific. So, look for that down gaze. So, if I can get out one message, that's one thing that can be easily done and examined fairly quickly for diagnosis of these patients. And then just look for signs of rigidity, bradykinesia, maybe even some myelopraxia, and then look at their gait carefully so that there's a high suspicion. Again, if there's some atypical features, imaging is really important. So, my next step would be probably getting an MRI to evaluate whether- do they have brain somatrophy or other widespread atrophy or other signs? You need to think about your differential diagnosis for some of these patients as well. So, common things are common; vascular disease, you can't have vascular parkinsonism or even signs of NPH. Both of those can present with progressive gait difficulty and falls. So, the gait may look more like Parkinson's rather than ataxic gait that we see in classic PSP, but still they have early gait issues, and that can be a mimicker of PSP, So looking for both of those things in your imaging. Think about sort of autoimmune potentially causes. So, if they have a really rapid progressive cause, there are some rare autoimmune things. There have been recent reports of things like IgLON5, although there's limited cases, but we're doing more screening for some of those autoimmune causes. And then even some infectious causes like Whipples, that are rarely present like this. Okay? And have other signs and features. Dr Monteith: So, let's say you diagnose this patient with PSP and you're assessing the patients to see how you can improve their quality of life. So, what are some potential symptomatic managements that will help our patient? Dr Farland: I recommend for most all of these patients… while the literature indicates that many patients with PSP, and especially corticobasal syndrome, don't respond well to levodopa. So, the classic treatment for parkinsonism. However, we all recommend a trial of levodopa. These patients may respond partially to doses of levodopa, and we try to push the doses a bit higher. So, the recommended trial is usually a dose up to roughly 1000 milligrams of levodopa per day. And give it some time, at least two, if not actually three months of a trial. If not well-tolerated, you can back off. If there's no response at all or no improvement, then slowly back off and taper patients off and ask them to tell you whether they feel like they're actually worsening. So, many patients, sometimes, don't recognize the improvements, or family members don't recognize it until we actually taper them back off. And they may end up saying there are some other things that even recognize. Even some nonmotor benefits can be seen with levodopa. In some cases, we do keep them on levodopa, but levodopa's our best therapy for this. Dopamine agonists, MAO inhibitors, have all been sort of tried and they've been studied, but often don't really help or fail to help benefit these patients and could be fraught with some other side effects. I think many people do also turn to Amantadine as a treatment for Parkinson's, gait problems, freezing, if you see it in these disorders. Yet Amantadine is fraught with issues of side effects, including cognitive issues, and I think is not well-tolerated. But there are the rare patient who actually does respond to this or claims they respond to this. By and large, these patients relentlessly progress, unfortunately. So, beside treatment of other symptoms, I think it's really important to recognize that they require supportive cares and therapy. So, starting those early on and getting your allied healthcares kind of involved. So that includes people like physical, occupational therapy for the gait issues, the falls, occupational therapy for doing daily activities. Speech language pathology can be really a critical player for these because of the early speech and language issues, as well as swallow difficulties. Swallow is compared quickly in these patients. And so, we do recommend the screening evaluation, then often following patients either every six- or even annually, at least, with a swallow evaluation. And we recommend the fluoroscopic-guided kind of modified barium swallow for these patients.  Dr Monteith: And how does that differ if, let's say, the patient had cortical basilar syndrome? What are some of the symptomatic treatments that would be high on your consideration? Dr Farland: So actually, these patients also have a very similar approach, and they often have some overlapping features. Maybe a little bit of difference in terms of the level of apraxia and some dystonic features that you see in corticobasal syndrome. So, as I mentioned earlier that these patients have a more typ- when they present, typically have a more asymmetric presentation. And one of the biggest issues is this limb apraxia. They may have abnormal movements as well as, like, the alien limb-type phenomena as well. So, the focus of therapy, while similar in the sense we focus on the parkinsonism, I do always try levodopa and try to ramp up the doses to see if it benefits. It does often fail, but it's definitely worth trying. The other focus of these patients is trying to treat symptoms. Dystonia, those features… in some cases, we can help; if it's painful or uncomfortable, muscle relaxants can be used. If it's vocal, things like Botox can be really helpful. Often times it is more palliative than actually restorative in terms of function, but still can be really helpful for patients who ask about pain and discomfort and trying to treat. And then of course, again, the focus on our supportive care. We need to build that network and build that team of folks, the therapists, the physical, occupational, and the speech therapist to help them. If they have language problems---like either in PSP or corticobasal---I'll also include my request to a speech language pathologist to work on cognitive function. That's a special, additional thing you have to ask for and then specifically request when you make a referral to a speech language pathologist. Dr Monteith: That is so important. I think keeping the simulation, keeping the social support, and I would probably guess that you would also include screening for sleep and mood disorder. Dr Farland: Absolutely. Mood disorders are really big in these diseases. Patients are suffering terribly. You do hear about labile mood in both of these diseases, particularly PSP; and even what's called pseudobulbar palsy, where the mood is not always congruent with the affect. So they may laugh or cry inappropriately, and particularly the crying can be very disturbing to family and caregivers to see that. And so, treating those things can be really important. So always asking about the mood issues. Depression in particular is something that we're very sensitive about, and there is a higher incidence of suicidal ideations. Asking about that and feeling and making sure that they are in a safe environment can be really important. Dr Monteith: Thank you so much. Dr Farland: Thank you. Dr Monteith: Today I've been interviewing Dr Nikolaus McFarland about his article on progressive supranuclear palsy and cortical basilar syndrome, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/RTX865. CME/MOC/NCPD/CPE/AAPA credit will be available until August 5, 2026.The LEAD Initiative: Clearing the Path to a Clinical and Neuropathological Diagnosis of Early Symptomatic Alzheimer's Disease in an Academic Center—Launchpad to Excellence in Alzheimer's Disease: A Quality Improvement ProjectThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/RTX865. CME/MOC/NCPD/CPE/AAPA credit will be available until August 5, 2026.The LEAD Initiative: Clearing the Path to a Clinical and Neuropathological Diagnosis of Early Symptomatic Alzheimer's Disease in an Academic Center—Launchpad to Excellence in Alzheimer's Disease: A Quality Improvement ProjectThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/RTX865. CME/MOC/NCPD/CPE/AAPA credit will be available until August 5, 2026.The LEAD Initiative: Clearing the Path to a Clinical and Neuropathological Diagnosis of Early Symptomatic Alzheimer's Disease in an Academic Center—Launchpad to Excellence in Alzheimer's Disease: A Quality Improvement ProjectThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/RTX865. CME/MOC/NCPD/CPE/AAPA credit will be available until August 5, 2026.The LEAD Initiative: Clearing the Path to a Clinical and Neuropathological Diagnosis of Early Symptomatic Alzheimer's Disease in an Academic Center—Launchpad to Excellence in Alzheimer's Disease: A Quality Improvement ProjectThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/RTX865. CME/MOC/NCPD/CPE/AAPA credit will be available until August 5, 2026.The LEAD Initiative: Clearing the Path to a Clinical and Neuropathological Diagnosis of Early Symptomatic Alzheimer's Disease in an Academic Center—Launchpad to Excellence in Alzheimer's Disease: A Quality Improvement ProjectThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/RTX865. CME/MOC/NCPD/CPE/AAPA credit will be available until August 5, 2026.The LEAD Initiative: Clearing the Path to a Clinical and Neuropathological Diagnosis of Early Symptomatic Alzheimer's Disease in an Academic Center—Launchpad to Excellence in Alzheimer's Disease: A Quality Improvement ProjectThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

When he was eight years old his father, Allen, disappeared. Allen left behind more than his children; he left a legacy of loss and family secrets. He was soon replaced by another man, one with his own four children, whose strict rules and explosive temper made home a place of fear rather than refuge.Though working just miles away as a veterinarian, Allen never saw Steven or his siblings until a grisly car accident a decade later forced a reunion of sorts. Would a relationship be possible? Was one even desired—by either party?Two men had claimed to be Steven's father but neither proved to be a dad. He would spend years wrestling with the wounds of abandonment and abuse, burying his pain so deep it became “the feeling of no feeling.” His search for acceptance, belonging, and purpose would lead him from Florida to Israel to law school to a fulfilling career helping and protecting others, but the rejection he felt in his childhood would also play a role in the failure of his first two marriages. Determined not to repeat the past, Steven sought therapy and became an unwavering presence in the lives of his five children.He is a graduate of Florida State University and the University of Florida College of Law. A practicing attorney and father of five, he has spent over thirty years advocating for children as a pro bono guardian ad litem and representing families of first responders killed on 9/11. As a founding partner of Page & Eichenblatt, he has received multiple awards for legal excellence and community work supporting children.He is the author of "Pretend They Are Dead: A Father's Search for the Truth.A memoir of resilience, Pretend They Are Dead reminds us of the pivotal role fathers play in the emotional well-being of their children and the ways in which childhood trauma can be overcome. https://www.amazon.com/Pretend-They-Are-Dead-Fathers-ebook/dp/B0F6VX4Z7W http://www.yourlotandparcel.org

Register your feedback here. Always good to hear from you!I got a couple of insiders for our discussion this week. Brent Clanton is a long-time radio celebrity in the Houston area and formerly served as shepherd for the Kleinwood church of Christ. Links to his work are included below. Phil Robertson worked in TV news in a former life; currently he is an associate vice president at Florida College. They're here to talk about the impact the news has on our lives as Christians.Check out Brent and The Real Investment Show with Lance Roberts at https://www.youtube.com/c/therealinvestmentshow and https://podcasts.apple.com/ca/podcast/the-real-investment-show-podcast/id1271435757Contact Phil Robertson at https://floridacollege.edu/employee/phil-robertson/Check out Hal on YouTube at https://www.youtube.com/@halhammons9705Hal Hammons serves as preacher and shepherd for the Lakewoods Drive church of Christ in Georgetown, Texas. He is the host of the Citizen of Heaven podcast. You are encouraged to seek him and the Lakewoods Drive church through Facebook and other social media. Lakewoods Drive is an autonomous group of Christians dedicated to praising God, teaching the gospel to all who will hear, training Christians in righteousness, and serving our God and one another faithfully. We believe the Bible is God's word, that Jesus died on the cross for our sins, that heaven is our home, and that we have work to do here while we wait. Regular topics of discussion and conversation include: Christians, Jesus, obedience, faith, grace, baptism, New Testament, Old Testament, authority, gospel, fellowship, justice, mercy, faithfulness, forgiveness, Twenty Pages a Week, Bible reading, heaven, hell, virtues, character, denominations, submission, service, character, COVID-19, assembly, Lord's Supper, online, social media, YouTube, Facebook.

In episode 208, Coffey talks with David Miklas about the Department of Labor's evolving definitions and interpretations of independent contractor classification under the Fair Labor Standards Act.  They discuss why DOL interpretations matter for FLSA compliance and overtime requirements; the shift from Biden administration's six-factor economic reality test back to Trump administration's emphasis on control and profit/loss opportunity; the six key factors including nature and degree of control, opportunity for profit and loss, permanence of relationship, worker investments, skill and initiative requirements, and how integral the work is to the principal business; common classification mistakes across industries including misunderstanding IRS versus DOL tests; the risks of supervision and control over workers classified as contractors; how technology can demonstrate control in gig economy situations; the financial consequences of misclassification including unpaid overtime, liquidated damages, and attorney fees; and the importance of proper written agreements and immediate legal consultation when classification issues arise. Good Morning, HR is brought to you by Imperative—Bulletproof Background Checks. For more information about our commitment to quality and excellent customer service, visit us at https://imperativeinfo.com.  If you are an HRCI or SHRM-certified professional, this episode of Good Morning, HR has been pre-approved for half a recertification credit. To obtain the recertification information for this episode, visit https://goodmorninghr.com.  About our Guest: David Miklas owns a Labor & Employment law firm and for 26 years he has practiced all types of labor and employment law exclusively representing Florida employers. He has written hundreds of employment law articles, is the co-author for the premier legal textbook used by lawyers for Florida employment law, is a frequent employment law presenter and is a nationally recognized speaker and an invited guest lecturer addressing employment law and human resource issues with over thirty universities, including Harvard. Mr. Miklas graduated from the University of Florida College of Law. David Miklas can be reached athttps://www.miklasemploymentlaw.com/https://www.linkedin.com/in/david-miklas-301861121/  About Mike Coffey: Mike Coffey is an entrepreneur, licensed private investigator, business strategist, HR consultant, and registered yoga teacher.In 1999, he founded Imperative, a background investigations and due diligence firm helping risk-averse clients make well-informed decisions about the people they involve in their business.Imperative delivers in-depth employment background investigations, know-your-customer and anti-money laundering compliance, and due diligence investigations to more than 300 risk-averse corporate clients across the US, and, through its PFC Caregiver & Household Screening brand, many more private estates, family offices, and personal service agencies.Imperative has been named a Best Places to Work, the Texas Association of Business' small business of the year, and is accredited by the Professional Background Screening Association.Mike shares his insight from 25+ years of HR-entrepreneurship on the Good Morning, HR podcast, where each week he talks to business leaders about bringing people together to create value for customers, shareholders, and community.Mike has been recognized as an Entrepreneur of Excellence by FW, Inc. and has twice been recognized as the North Texas HR Professional of the Year. Mike serves as a board member of a number of organizations, including the Texas State Council, where he serves Texas' 31 SHRM chapters as State Director-Elect; Workforce Solutions for Tarrant County; the Texas Association of Business; and the Fort Worth Chamber of Commerce, where he is chair of the Talent Committee.Mike is a certified Senior Professional in Human Resources (SPHR) through the HR Certification Institute and a SHRM Senior Certified Professional (SHRM-SCP). He is also a Yoga Alliance registered yoga teacher (RYT-200) and teaches multiple times each week. Mike and his very patient wife of 28 years are empty nesters in Fort Worth.   Learning Objectives: 1.       Evaluate worker relationships using the Trump Administration's six-factor economic reality test.2.       Differentiate between US Department of Labor independent contractor definitions and those of the and IRS and state regulators.3.       Respond appropriately to classification concerns to avoid liability.

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including:The information to collect during patient visitsThe available resources to help you submit prior authorizationsThe supporting documents that are often necessary to accompany prior authorizationsHow to address denials and appealsWhen to access manufacturer-based or foundation-based financial assistancePresentersJoseph Kim, MD, MPH, MBAPresidentQ Synthesis, LLCNewtown, PennsylvaniaManish Shah, MDClinical Associate Faculty MS1 PreceptorUniversity of Florida College of MedicineGainesville, FloridaMartha Grugel, MAMedical AssistantWesley Chapel, FloridaLink to full program: https://bit.ly/45P0v8z

#606: Hospice nurse and end-of-life educator Suzanne O'Brien joins us to discuss the financial realities of dying in America — and they might surprise you. Remember Aretha Franklin? Her handwritten will was found in her couch cushions after she passed away. Despite her substantial wealth, this simple document was legally upheld. It's a powerful reminder that having any form of will is better than none at all. But there's more to worry about than just having a will or trust. The costs of aging and dying can add up fast. Long-term care costs can quickly deplete even substantial savings. Suzanne shares a story about a couple with over $5 million who were shocked to learn how quickly 24/7 care for dementia would consume their nest egg. Traditional funerals average between $7,000-$11,000, but there are much more affordable alternatives: Home wakes and natural burials can cost just a few hundred dollars Water cremation offers an environmentally friendly option Whole body donation to medical institutions costs nothing while contributing to education Planning ahead gives you control over these decisions and spares your loved ones additional stress. Multi-generational living arrangements can also reduce caregiving costs and address concerns like isolation and safety for aging family members. Suzanne also shares stories about the emotional side of dying. Did you know some people seem to choose when they go? She tells us about a 99-year-old woman in a coma who somehow held on for days until she turned 100, then passed away that very night. Resources Mentioned: Anatomical Board of the State of Florida » College of Medicine » University of Florida US Programs » Anatomical Board of the State of Florida » College of Medicine » University of Florida NATIONAL HOME FUNERAL ALLIANCE - Home Learn more about your ad choices. Visit podcastchoices.com/adchoices

Thank you for tuning in for another episode of Life's Best Medicine. Dr. Laura Buchanan is a double board-certified physician in family and obesity medicine with a passion for using lifestyle modification as the first-line standard of care. She is a certified metabolic health practitioner (MHP), and a Board and founding member of the Society of Metabolic Health Practitioners. She is also a certified Menopause Society Certified Practitioner (MSCP). Given the improvement she has seen in patient's mental health with low-carb diets, she also completed Dr. Georgia Ede's “Ketogenic Diets for Mental Health Clinician Training”. She completed her family medicine residency at Wake Forest in 2022 and was a valedictorian of her class at the University of Florida College of Medicine. In this episode, Drs. Brian and Laura talk about… (00:00) Intro (03:34) How Dr. Laura first became interested in metabolic health and her research work at Toward Health (06:11) Data and research on quality of life and mental health improvement for people on a keto diet (08:04) How Alzheimer's can improve on low-carb and ketogenic diets (09:19) The prevalence of food addiction among obese and diabetic people (10:43) Harm reduction versus abstinence strategies for dealing with food addiction (14:15) Some harmful ingredients found in many keto and low-carb replacement foods (17:10) Toward Health's upcoming study on the improvement of binge eating and food addiction symptoms on a low carb diet (20:55) Some strategies that can help people recover from binge eating and food addiction (23:30) Night-Eating Syndrome (26:37) The importance of community and engagement with people who can support you through your recovery and health journey (29:16) The incredible findings of Toward Health's employee wellness program study (33:38) The economic/medical pros and cons of GLP-1 medications (39:55) Sneaky sugars that most people are not aware of (46:42) The key take-aways from Toward Health's recent Employee Wellness study (57:24) Outro and plugs   For more information, please see the links below. Thank you for listening!   Links:   Resources Mentioned in this Episode: DR DAVID UNWIN'S SUGAR INFOGRAPHICS: https://phcuk.org/sugar/ The Society of Metabolic Health Practitioners: https://thesmhp.org   Dr. Laura Buchanan:: Toward Health App: https://toward.health/community/ Toward Health Employee Wellness Study: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1548609/full Twitter: https://twitter.com/LauraBuchananMD Website: https://www.iheartvitae.com/ Instagram: https://www.instagram.com/iheartvitae/?hl=en The Food Relationship Fix: https://toward.health/food-addiction-webinar/   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. Laura Buchanan is board certified in Family Medicine and is on the board of the Society of Metabolic Health Practitioners. She graduated summa cum laude with a Bachelor of Science in Biomedical Sciences from the University of South Florida and was a valedictorian of her class at the University of Florida College of Medicine. She is on staff at Dr. Tro's Medical Weight Loss & Direct Primary Care. In this episode, Dr. Tro and Dr. Laura talk about… (00:00) Intro (03:19) When and how Dr. Laura knew she wanted to go into some form of medical practice and become a doctor (07:25) Dr. Laura's experience working at a small rural hospital in Peru (09:15) The story of how Dr. Laura met her husband, Dr. Matt Calkins (10:31) Some of the most prominent issues with Western medical education and standard nutritional information (14:39) Issues with the medical insurance system in the United States (21:50) Dr. Tro's Employee Wellness Program (26:15) The initial 6 month data results of Dr. Tro and Dr. Laura's employee wellness program study (see links below) (28:59) The incredible effectiveness of DPC and remote monitoring and remote patient care (33:51) The most important findings presented in the Toward Health paper  (36:30) The GLP-1 medications' benefits and downsides for weight loss and metabolic health (43:35) The highlight findings of the Toward Health study (49:52) Outro For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Resources Mentioned in this Episode: The Toward Health Study: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1548609/full Dr. Laura Buchanan: Twitter The Society of Metabolic Health Practitioners Website Instagram Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

Are small tweaks in your marketing strategy costing you big wins? From email subject lines to debunking commonly-held myths, simple changes can unlock massive improvements.Today we're exploring the art of finding small changes with big impacts in marketing with Jay Schwedelson, Founder of SubjectLine.com, CEO of Outcome Media, and host of the Do This, Not That! podcast. We'll discuss how research-backed insights fuel his success, myths holding marketers back, and more.Jay Schwedelson is one of the top marketing experts in the U.S., renowned for providing marketers with the latest research-backed insights and best practices.As the founder of SubjectLine.com, the top free subject-line rating tool globally, Jay has tested over 15 million subject lines, helping organizations master impactful emailmarketing. He also founded GURU Media Hub, which hosts the GURU conference, the world's largest email marketing event, and other major marketing gatherings attracting over 50,000 attendees annually.Jay's podcast, “Do This, Not That!: For Marketers,” consistently ranks in the top 10 of over 50,000 marketing podcasts in the U.S. and is in the top 0.5% of podcasts globally.Through his agency, Outcome Media, Jay's team executes over 40,000 marketing campaigns each year for iconic brands. He has been named to Crain's Top 100 IndustryLeaders for 10 consecutive years and is in the Hall of Fame at the University of Florida College of Journalism and Communications.With his unique blend of expertise, Jay shares super tactical tips on marketing, specifically email marketing, content marketing, and LinkedIn strategies.RESOURCESWix Studio is the ultimate web platform for creative, fast-paced teams at agencies and enterprises—with smart design tools, flexible dev capabilities, full-stack business solutions, multi-site management, advanced AI and fully managed infrastructure. https://www.wix.com/studioDon't miss Medallia Experience 2025, March 24-26 in Las Vegas: Registration is now available: https://cvent.me/AmO1k0Use code MEDEXP25 for $200 off registrationRegister now for HumanX 2025. This AI-focused event brings some of the most forward-thinking minds in technology together. Register now with the code "HX25p_tab" for $250 off the regular price.Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstromDon't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.showCheck out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.comThe Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnowThe Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company Hosted on Acast. See acast.com/privacy for more information.

Are small tweaks in your marketing strategy costing you big wins? From email subject lines to debunking commonly-held myths, simple changes can unlock massive improvements. Today we're exploring the art of finding small changes with big impacts in marketing with Jay Schwedelson, Founder of SubjectLine.com, CEO of Outcome Media, and host of the Do This, Not That! podcast. We'll discuss how research-backed insights fuel his success, myths holding marketers back, and more. Jay Schwedelson is one of the top marketing experts in the U.S., renowned for providing marketers with the latest research-backed insights and best practices. As the founder of SubjectLine.com, the top free subject-line rating tool globally, Jay has tested over 15 million subject lines, helping organizations master impactful email marketing. He also founded GURU Media Hub, which hosts the GURU conference, the world's largest email marketing event, and other major marketing gatherings attracting over 50,000 attendees annually. Jay's podcast, “Do This, Not That!: For Marketers,” consistently ranks in the top 10 of over 50,000 marketing podcasts in the U.S. and is in the top 0.5% of podcasts globally. Through his agency, Outcome Media, Jay's team executes over 40,000 marketing campaigns each year for iconic brands. He has been named to Crain's Top 100 Industry Leaders for 10 consecutive years and is in the Hall of Fame at the University of Florida College of Journalism and Communications. With his unique blend of expertise, Jay shares super tactical tips on marketing, specifically email marketing, content marketing, and LinkedIn strategies. RESOURCES Wix Studio is the ultimate web platform for creative, fast-paced teams at agencies and enterprises—with smart design tools, flexible dev capabilities, full-stack business solutions, multi-site management, advanced AI and fully managed infrastructure. https://www.wix.com/studio Don't miss Medallia Experience 2025, March 24-26 in Las Vegas: Registration is now available: https://cvent.me/AmO1k0 Use code MEDEXP25 for $200 off registration Register now for HumanX 2025. This AI-focused event brings some of the most forward-thinking minds in technology together. Register now with the code "HX25p_tab" for $250 off the regular price. Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstrom Don't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.show Check out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnow The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company